BRIDGEWATER, N.J., Oct. 30, 2018 /PRNewswire/ — The United States Food and Drug Administration (FDA) has accepted a Biologics License Application for Sanofi Pasteur's dengue vaccine. The dengue vaccine candidate has been granted priority…Original Article
FDA Grants Priority Review for Sanofi’s Dengue Vaccine Candidate
